International Mentoring Foundation for the Advancement of Higher Education

Rocío López-Diego MD, PhD.

Cofounder/Director, IMFAHE.
Former Director of Development and Strategic Initiatives, IMP. 

Dr. López-Diego obtained her MD with top national honors (Extraordinary Medical Licensure Award) at the University of Valencia School of Medicine, Spain, in 1995. Since then, Dr. López-Diego has pursued her career in the USA.  She obtained her PhD in Molecular Microbiology and Immunology (University of Southern California, Los Angeles), with focus on retroviral insertional mutagenesis tools for the identification of novel oncogenes in mouse models of breast cancer, distinguished with the nationally-competitive Dept. of Defense CDRP Breast Cancer Pre-doctoral Research Award.  She subsequently completed her Adult Neurology residency (University of Michigan, Ann Arbor), and moved onto postdoctoral research fellowship on Human Immunology and clinical fellowship specialization in Multiple Sclerosis at Harvard University/Brigham & Women’s Hospital, Boston, distinguished with a 2-yr National Multiple Sclerosis Society Postdoctoral Research Award. As Neurology Faculty, she has fulfilled roles as Associate Neurologist and Multiple Sclerosis Specialist (Dept. of Neurology, Brigham & Women’s Hospital/Harvard Medical School), Senior Neurology Advisor (Dept. of Global Psychiatry, Massachusetts General Hospital/Harvard Medical School), and Chief of Neurology (Harvard Vanguard Medical Associates).

She is currently the Founder of THiNKBrain, a private consultancy in health strategy and social equit, focused on the re-definition of the concept of individual and social health, and the development of innovative integrative eco-social approaches to health and global wellbeing promotion. Most recent projects include diagnosis and integrative care of complex neurologic and multiple sclerosis patients; mental and brain health promotion and educator/professional caregiver capacity building in developing countries; addressing the rising non-communicable disease epidemic and its inclusion as stand-alone national and international health promotion priority; and the creation of new effective models of remote, real time, telemedicine care.